Explore more publications!
Oklahoma Healthcare Wire
Got News to Share?

Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on March 19, 2026

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026
Mar. 19, 2026

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
Mar. 19, 2026

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025
Mar. 19, 2026

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

Indeterminate GlobeNewswire
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
Mar. 19, 2026

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

Indeterminate GlobeNewswire
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Mar. 19, 2026

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Indeterminate GlobeNewswire
Gain Therapeutics to Present at the 38th Annual ROTH Conference
Mar. 19, 2026

Gain Therapeutics to Present at the 38th Annual ROTH Conference

Indeterminate GlobeNewswire
Kaida BioPharma Announces Executive Leadership Team to Advance KAD-101, Built for the Ovarian Cancer Gap
Mar. 19, 2026

Kaida BioPharma Announces Executive Leadership Team to Advance KAD-101, Built for the Ovarian Cancer Gap

Indeterminate GlobeNewswire
$1M Donation by Lume Deodorant Founder Marks the Largest Single Gift to Fund Lobular Breast Cancer Research
Mar. 19, 2026

$1M Donation by Lume Deodorant Founder Marks the Largest Single Gift to Fund Lobular Breast Cancer Research

Indeterminate GlobeNewswire
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
Mar. 19, 2026

Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026

Indeterminate GlobeNewswire
Teva Releases Q1 2026 Aide Memoire
Mar. 19, 2026

Teva Releases Q1 2026 Aide Memoire

Indeterminate GlobeNewswire
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
Mar. 19, 2026

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

Indeterminate GlobeNewswire
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar. 19, 2026

Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar. 19, 2026

Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Mar. 19, 2026

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Indeterminate GlobeNewswire
Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2025
Mar. 19, 2026

Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2025

Indeterminate GlobeNewswire
Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Mar. 19, 2026

Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire
Curia erweitert seine Produktionskapazitäten in Glasgow und verbessert seine Plattform zur Entwicklung von Zelllinien
Mar. 19, 2026

Curia erweitert seine Produktionskapazitäten in Glasgow und verbessert seine Plattform zur Entwicklung von Zelllinien

Indeterminate GlobeNewswire
Curia renforce ses capacités de production à Glasgow et consolide sa plateforme de développement de lignées cellulaires
Mar. 19, 2026

Curia renforce ses capacités de production à Glasgow et consolide sa plateforme de développement de lignées cellulaires

Indeterminate GlobeNewswire
קוריה מרחיבה את כושר הייצור של גלזגו ומשפרת את פלטפורמת פיתוח קווי התאים
Mar. 19, 2026

קוריה מרחיבה את כושר הייצור של גלזגו ומשפרת את פלטפורמת פיתוח קווי התאים

Indeterminate GlobeNewswire
Curia Memperluas Kapasitas Manufaktur Glasgow dan Meningkatkan Platform Pengembangan Lini Sel
Mar. 19, 2026

Curia Memperluas Kapasitas Manufaktur Glasgow dan Meningkatkan Platform Pengembangan Lini Sel

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions